CN105385601B - A kind of nosema locustae and its suspension culture method and application - Google Patents
A kind of nosema locustae and its suspension culture method and application Download PDFInfo
- Publication number
- CN105385601B CN105385601B CN201510890754.3A CN201510890754A CN105385601B CN 105385601 B CN105385601 B CN 105385601B CN 201510890754 A CN201510890754 A CN 201510890754A CN 105385601 B CN105385601 B CN 105385601B
- Authority
- CN
- China
- Prior art keywords
- spore
- culture
- locust
- microsporidian
- nosema locustae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000486791 Antonospora locustae Species 0.000 title claims abstract description 100
- 238000000034 method Methods 0.000 title claims abstract description 35
- 238000004114 suspension culture Methods 0.000 title claims abstract description 10
- 239000001963 growth medium Substances 0.000 claims abstract description 83
- 229920002101 Chitin Polymers 0.000 claims abstract description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 50
- 230000006196 deacetylation Effects 0.000 claims abstract description 28
- 238000003381 deacetylation reaction Methods 0.000 claims abstract description 28
- 241000238631 Hexapoda Species 0.000 claims abstract description 22
- 241000690711 Locusta migratoria migratoria Species 0.000 claims abstract description 22
- 238000000926 separation method Methods 0.000 claims abstract description 22
- 238000000338 in vitro Methods 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 8
- 239000002917 insecticide Substances 0.000 claims abstract description 6
- 241000254022 Locusta migratoria Species 0.000 claims abstract description 5
- 210000004215 spore Anatomy 0.000 claims description 200
- 239000007788 liquid Substances 0.000 claims description 43
- 210000003046 sporozoite Anatomy 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 22
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 9
- 239000012894 fetal calf serum Substances 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 8
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 8
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 claims description 8
- 229960002885 histidine Drugs 0.000 claims description 8
- 244000005700 microbiome Species 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- QIVBCDIJIAJPQS-UHFFFAOYSA-N tryptophan Chemical compound C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 8
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 8
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Natural products OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 7
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 7
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000004062 sedimentation Methods 0.000 claims description 6
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 230000014759 maintenance of location Effects 0.000 claims description 5
- 239000001103 potassium chloride Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 4
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 235000019743 Choline chloride Nutrition 0.000 claims description 4
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 claims description 4
- 229910021592 Copper(II) chloride Inorganic materials 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 4
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 4
- 229930091371 Fructose Natural products 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 4
- 239000004201 L-cysteine Substances 0.000 claims description 4
- 235000013878 L-cysteine Nutrition 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 4
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 101150090155 R gene Proteins 0.000 claims description 4
- 239000004473 Threonine Substances 0.000 claims description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 4
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 4
- 229960005261 aspartic acid Drugs 0.000 claims description 4
- 229940000635 beta-alanine Drugs 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 235000001465 calcium Nutrition 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 4
- 229960003178 choline chloride Drugs 0.000 claims description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 4
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 4
- ASIYFCYUCMQNGK-JZGIKJSDSA-L disodium L-tyrosinate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CC1=CC=C([O-])C=C1 ASIYFCYUCMQNGK-JZGIKJSDSA-L 0.000 claims description 4
- 229910052564 epsomite Inorganic materials 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 4
- 238000012423 maintenance Methods 0.000 claims description 4
- 239000001630 malic acid Substances 0.000 claims description 4
- 235000011090 malic acid Nutrition 0.000 claims description 4
- 239000011565 manganese chloride Substances 0.000 claims description 4
- 239000002609 medium Substances 0.000 claims description 4
- 229910052603 melanterite Inorganic materials 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019192 riboflavin Nutrition 0.000 claims description 4
- 239000002151 riboflavin Substances 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 4
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 4
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 4
- 229960002898 threonine Drugs 0.000 claims description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 4
- 239000004474 valine Substances 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims description 4
- 108700026215 vpr Genes Proteins 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 239000011592 zinc chloride Substances 0.000 claims description 4
- HFVMEOPYDLEHBR-UHFFFAOYSA-N (2-fluorophenyl)-phenylmethanol Chemical compound C=1C=CC=C(F)C=1C(O)C1=CC=CC=C1 HFVMEOPYDLEHBR-UHFFFAOYSA-N 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 229930010555 Inosine Natural products 0.000 claims description 3
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-UHNVWZDZSA-N L-allo-Isoleucine Chemical compound CC[C@@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-UHNVWZDZSA-N 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- 229930182816 L-glutamine Natural products 0.000 claims description 3
- 229930182844 L-isoleucine Natural products 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000000413 hydrolysate Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 3
- 229960003786 inosine Drugs 0.000 claims description 3
- 229960000310 isoleucine Drugs 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000001384 succinic acid Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 2
- 229930195722 L-methionine Natural products 0.000 claims description 2
- 229960004452 methionine Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 claims 1
- 241000432824 Asparagus densiflorus Species 0.000 claims 1
- 102000006395 Globulins Human genes 0.000 claims 1
- 108010044091 Globulins Proteins 0.000 claims 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 claims 1
- CLHQKORMKHTVSA-ILKKLZGPSA-N [Na].[Na].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Na].[Na].C(CC)N[C@@H](CCO)C(=O)O CLHQKORMKHTVSA-ILKKLZGPSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- PMMYEEVYMWASQN-IMJSIDKUSA-N cis-4-Hydroxy-L-proline Chemical compound O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 claims 1
- 241000243190 Microsporidia Species 0.000 abstract description 140
- 239000000725 suspension Substances 0.000 abstract description 15
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract description 8
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract description 8
- 230000003321 amplification Effects 0.000 abstract description 6
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 6
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 6
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 5
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract description 4
- 239000003932 viscosupplement Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 29
- 201000010099 disease Diseases 0.000 description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 26
- 241001126829 Nosema Species 0.000 description 21
- 241000196324 Embryophyta Species 0.000 description 19
- 239000002953 phosphate buffered saline Substances 0.000 description 19
- 210000001563 schizont Anatomy 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 19
- 241000819999 Nymphes Species 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 17
- 210000002966 serum Anatomy 0.000 description 17
- 208000015181 infectious disease Diseases 0.000 description 15
- 230000012010 growth Effects 0.000 description 13
- 235000002639 sodium chloride Nutrition 0.000 description 13
- 241000607479 Yersinia pestis Species 0.000 description 12
- 238000011161 development Methods 0.000 description 12
- 230000018109 developmental process Effects 0.000 description 12
- 238000003306 harvesting Methods 0.000 description 12
- 231100000518 lethal Toxicity 0.000 description 12
- 230000001665 lethal effect Effects 0.000 description 12
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- 230000035755 proliferation Effects 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- 230000028070 sporulation Effects 0.000 description 10
- 210000000130 stem cell Anatomy 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- 238000009395 breeding Methods 0.000 description 9
- 230000001488 breeding effect Effects 0.000 description 9
- 210000000805 cytoplasm Anatomy 0.000 description 9
- 239000012153 distilled water Substances 0.000 description 9
- 238000004043 dyeing Methods 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 210000000170 cell membrane Anatomy 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 210000003934 vacuole Anatomy 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000004993 binary fission Effects 0.000 description 6
- 244000309466 calf Species 0.000 description 6
- 210000002468 fat body Anatomy 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 230000001788 irregular Effects 0.000 description 6
- 239000011049 pearl Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 241000948875 Antonospora scoticae Species 0.000 description 5
- 102000003505 Myosin Human genes 0.000 description 5
- 108060008487 Myosin Proteins 0.000 description 5
- 241000648137 Nosema whitei Species 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000012790 confirmation Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000002054 inoculum Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000001376 precipitating effect Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 108700022487 rRNA Genes Proteins 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 241001126828 Nosema bombycis Species 0.000 description 4
- 108010019160 Pancreatin Proteins 0.000 description 4
- 241000382353 Pupa Species 0.000 description 4
- 230000021736 acetylation Effects 0.000 description 4
- 238000006640 acetylation reaction Methods 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229910001424 calcium ion Inorganic materials 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 229910001425 magnesium ion Inorganic materials 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 229940055695 pancreatin Drugs 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000000405 serological effect Effects 0.000 description 4
- 239000001509 sodium citrate Substances 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 108010034145 Helminth Proteins Proteins 0.000 description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 244000000013 helminth Species 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000575 pesticide Substances 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- DAULJXMTHKRKSK-JIZZDEOASA-N (2r)-2-amino-3-sulfanylpropanoic acid;sodium Chemical compound [Na].[Na].SC[C@H](N)C(O)=O DAULJXMTHKRKSK-JIZZDEOASA-N 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241001573925 Gleba Species 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 241000446313 Lamella Species 0.000 description 2
- 201000000090 Microsporidiosis Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 206010036590 Premature baby Diseases 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- IYPRWQPJYRBHIS-UHFFFAOYSA-N acetic acid;uranium Chemical compound [U].CC(O)=O IYPRWQPJYRBHIS-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000001085 differential centrifugation Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 238000005304 joining Methods 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000011177 media preparation Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000000633 nuclear envelope Anatomy 0.000 description 2
- 210000004940 nucleus Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 238000013081 phylogenetic analysis Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000003705 ribosome Anatomy 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000010148 water-pollination Effects 0.000 description 2
- 235000015099 wheat brans Nutrition 0.000 description 2
- QWWVBNODQCWBAZ-WHFBIAKZSA-N (2r)-2-amino-3-[(2r)-2-carboxy-2-(methylamino)ethyl]sulfanylpropanoic acid Chemical compound CN[C@H](C(O)=O)CSC[C@H](N)C(O)=O QWWVBNODQCWBAZ-WHFBIAKZSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- CNNSWSHYGANWBM-UHFFFAOYSA-N 6-chloro-2,3-dimethylquinoxaline Chemical compound C1=C(Cl)C=C2N=C(C)C(C)=NC2=C1 CNNSWSHYGANWBM-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 241000948873 Antonospora Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 238000002738 Giemsa staining Methods 0.000 description 1
- 241000346164 Locusta migratoria manilensis Species 0.000 description 1
- 241001295810 Microsporidium Species 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 241000243216 Vairimorpha Species 0.000 description 1
- 241000241816 Vairimorpha ceraces Species 0.000 description 1
- 241000243224 Vairimorpha necatrix Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- ABUBSBSOTTXVPV-UHFFFAOYSA-H [U+6].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O Chemical compound [U+6].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ABUBSBSOTTXVPV-UHFFFAOYSA-H 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- HWXBTNAVRSUOJR-UHFFFAOYSA-N alpha-hydroxyglutaric acid Natural products OC(=O)C(O)CCC(O)=O HWXBTNAVRSUOJR-UHFFFAOYSA-N 0.000 description 1
- 229940009533 alpha-ketoglutaric acid Drugs 0.000 description 1
- -1 ammonia Amide Chemical class 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000034303 cell budding Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000002654 craniosacral therapy Methods 0.000 description 1
- 230000021953 cytokinesis Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000012137 double-staining Methods 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 230000005584 early death Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000000967 entomopathogenic effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000001538 fat body cell Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 230000005571 horizontal transmission Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000005001 merogony Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229910052762 osmium Inorganic materials 0.000 description 1
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 210000004508 polar body Anatomy 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 102220041265 rs587778687 Human genes 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000005002 sporogony Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000007070 tosylation reaction Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000005570 vertical transmission Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000020138 yakult Nutrition 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a kind of nosema locustae and its suspension culture method and applications.Wherein, the nosema locustae strain reached for 10 generations for the separation from Asiatic migratory locust (Locusta migratoria L.) in locust body, and in vitro culture obtains after reaching for 10 generations, and deposit number is CGMCC No.11170.Further; the invention also provides a kind of culture mediums and suspension culture method in vitro culture nosema locustae; the culture medium using insect source property, water solubility, deacetylation chitin as extracellular matrix; polyvinylpyrrolidone is as visco-supplement; it is added to protein extract simultaneously; microcarrier suspension amplification cultivation is carried out using culture medium disclosed by the invention, using bioreactor, the microsporidian number through microcarrier suspension culture is enabled to reach 60 times that starting is cultivated.The present invention provides a kind of method of external mass propgation nosema locustae, the large-scale use for nosema locustae as biological insecticides provides technical support.
Description
Technical field
The present invention relates to one plant of nosema locustae, further relate to a kind of in vitro culture nosema locustae culture medium and
Cultural method, the invention belongs to agricultural biological technical fields.
Background technique
Locust is the pest for influencing agriculture-stock production, in China pastoral area, seriously endangers grassland, in order to kill locust, all the year round
Chemical pesticide, but chemical pesticide not only somewhat expensive, but also pollution environment are largely used, causes residue of pesticide in livestock products, together
When kill Natural Enemies of Grasshopper, cause community function to deteriorate.It therefore can as biological insecticides by using entomopathogenic microorganism
Greatly reduce the destruction to natural environment.
Microsporidian is one of locust pathogenic microorganisms, and microsporidiosis is caused by microsporidian, in the place of infection
It is bred in chief cell by schizont, spore phase.Since microsporidian plays a significant role in adjusting insect population.Locust is micro-
Sporozoite cause of disease introduces pest population, causes microsporidian disease popularity, facilitates the solution inscribed between locust, and be possible to longer
Phase plays the effect of its natural contral.
Nosema locustae is to belong to Microspora (Microspora), Microsporidea (Microsporea), micro- spore
Sub- worm mesh (Microsporida), Nosema (Nosema) single-celled protozoal animal, battalion cytozoicus life.It is typical
Stage is the spore of dormant period, there is the polar filament of a sporoplasm and a helical coil in spore, after host eats spore
Under the action of middle intestines alkaline digest liquid, spore inner disk around polar filament quickly turn up, pierce through the funnel and enteric epithelium of host,
Sporoplasm, which injects host's midgut epithelial cells by hollow polar filament pipe, simultaneously becomes small deformation body.A part of deformable body is just thin in middle intestines
Development intracellular, and most of deformable body reaches sensitivity tissue by hemolymph, generates segmenta through schizogamy after, then
Into the sporogenesis phase, by double-core gleba and spore mother cell's stage, cell, which further breaks up, eventually forms ellipse
Mature spore.Mitochondrial is free of in microsporidian body.
There are two types of the circulation way of nosema locustae in nature, i.e. horizontal transmission and vertical transmission.First is that due to
Host has eaten by the food of spore contamination or cannibalism and has made mutually to infect between individual, second is that due to organizing generating process
In, the surface that segmenta or gleba have infected ovary or spore contamination ovum makes pathogen be directly delivered to filial generation from parental generation.
It is mainly shown as feeding exception after locust infection, grows irregular, mutual residual, fecundity and service life reduction.Due to cytoclasis and
The result of nutrient consumption causes polypide dead.The size of illness depends on susceptible degree and range and the hair of infected host
Educate the stage.
At home and abroad nosema locustae was once widely studied the safety of vertebrate, and result of study shows: locust
Worm microsporidian is safe to vertebrate, while also not having infectivity to honeybee, and therefore, nosema locustae becomes commodity
The microsporidian insecticide of change is promoted the use of.
In the past 20 years, it is frequently found some and typical locust granulosis cause of disease-nosema locustae throughout our country
The form of (Nosema bombycis, Nb), special-shaped microsporidian of different sizes.These special-shaped microsporidians are mainly derived from
Field Asiatic migratory locust (Locusta migratoria L.), and the rising of nosema locustae disease incidence and field Ya Zhou
Migratory locusts microsporidian is related to the cross-infection of locust.Investigation finds that a variety of fields advantage locust also has very high micro- spore
Sick Natural infection rate, wherein 1 plant of microsporidian being collected into out of field Asiatic migratory locust body all has under certain food locust
Appeal.
Microsporidian conventional sorting methods mainly according to its history of life, ultra microstructure, serological relation, host range, post
Main tissue specificity, spore shape size etc..The development of Protocols in Molecular Biology carries out system to locust cause of disease from molecular level
Study on Evolution and taxonomic identification are widely used.The SSU rRNA of microsporidian, rRNA ITS gene order have height
Conservative, thus become a kind of important auxiliary tool for carrying out molecular biology classification and the systematic growth research of microsporidian.
The SSU rRNA gene of microsporidian determines micro- spore suitable for the affiliation between analysis Nosema in the level of category
The classification position of sub- worm.RRNA ITS is larger in biological species and subspecies variation, point that can be used in the level of microsporidian kind
Class.The present invention carries out biological characteristic research to the 1 plant of microsporidian collected out of Xinjiang field Asiatic migratory locust body, is based on SSU
RRNA, rRNA ITS gene order carry out the Molecular Phylogeny analysis of microsporidian, are its taxonomic identification and tracking locust
The infection genesis of microsporidiosis, and effectively the harm of control locust provides foundation.
Nosema locustae is used for biological locust elimination as biological insecticides, first has to solve the problems, such as its production, currently the only
Reliable method is living body propagation, but breeds microsporidian with the locust nymph of a locust, many challenges is faced, as onerous toil is strong
Degree needs the mass rearing of the nymph of a locust, is crushed, the prevention of nymph of a locust other diseases.And directly with appropriate media culture or suitable elder brother
The extracorporeal culturing method of worm cell culture nosema locustae is still in the exploratory stage.
Summary of the invention
The first technical problem to be solved by the present invention be to provide it is a kind of obtained through separation, and can be suitable for external outstanding
The nosema locustae strain of floating culture;
The second technical problem to be solved by the present invention, which is to provide, a kind of can be directly used for culture nosema locustae
Culture medium and extracorporeal culturing method.
In order to achieve the above object, present invention employs following technological means:
Inventor is separated to 1 plant of micro- spore out of In Altay, xinjiang Burqin County field Asiatic migratory locust body
Worm, research find its biological characteristics with micro- spore category (Nosema): microscopically observation polypide shape is in oval,
With nosema locustae (Nosema locustae) no significant difference.Fat body cells and haemocyte of the main parasitic in locust
In, all stage cores are double-core.Mature spore is oval, and the fresh microsporidian size for applying on piece is 4.5 ± 0.16 μ ms
2.2 ± 0.07 μm (n=10), it is 1.4 ± 0.07 μm of 3.3 ± 0.06 μ m (n=10) that ultra-thin section, which powers on sem observation size,.It is super
Micro-structure and nosema locustae are most like.The micro- spore history of life big multistage is double-core, includes many Electron-dense bodies.Jim
The spore of monokaryon is also accidentally observed in the smear of Sha's dyeing and ultra-thin section face, has monokaryotic stage in the spore development later period.Polar filament with
Spore long axis oblique angle is 60-70 degree, and polar filament inclination angle and locust sporozoite are variant.Ultra microstructure shows micro- spore category of separation
In the micro- spore category of locust.
It is host with the 2 age in days nymph of a locust of locust, observes this plant of microsporidian in locust (Locusta migratoria L.) children
The history of life growth course of enteral in worm.As a result, it has been found that: most of stages of its history of life are double-core, and the spore development later period is presented
Monokaryon is the result for have binary fission.The spore fragmentation phase (sporogony) is double-core, generates the spore of single form.Respectively
A stage of development is all in the cytoplasm of host.Spore shape be oval or oval cylindricality, 200-300nm of inner wall thickness, outside
40-60nm of wall thickness.Mature spore contains 3-12 polar filament circles, and there are a large amount of vacuoles in spore rear end.Outside immature spore, there is electronics
Dense matter package, side rise and fall, the cytosome (shell of the tight in front-end and back-end) with two side shells;Cytosome
Slightly locate rearward positioned at double-core center or double-core.Polar filament pipeloop number 15-20,1-2 row arrange irregular alignment.This plant of microsporidian spore
The internal structure of son has double-core and similar polar filament circle number, but its polar filament inclination angle 60-70 degree as the micro- spore of locust,
It is smaller than locust sporozoite.The history of life of this plant of microsporidian and locust sporozoite are very close, can find in adipose tissue, raw
There are uninucleate stage, the single form spore containing outer wall and inner wall in the history development starting phase living.The history of life in all stages directly and host
Cytoplasm contact, is proliferated in a manner of binary fission, eventually forms double-core maturation spore.
With anti-locust sporozoite serum aggregation can occur for isolated microsporidian, illustrate there is phase with locust sporozoite
Same surface antigen.
From form, from the history of life, preliminary judgement belongs to the micro- spore category of locust to isolated microsporidian.
Separate the SSU rDNA and nosema locustae N.locustae and Antonospora of micro- spore
The SSU rDNA sequence of scoticae is compared, and finds there is 5% between micro- spore and nosema locustae N.locustae
Difference and Antonospora scoticae have 10% difference.The phylogenetic tree that microsporidian SSU rRNA sequence is established
Confirm that this plant of microsporidian belongs to Nosema category.The similitude and Genetic Distance Analysis of SSU rRNA sequence show this plant of micro- spore
The affiliation of worm and nosema locustae is close.The similitude and Genetic Distance Analysis of rRNA ITS gene order show the strain
The similitude of microsporidian and nosema locustae is higher, and degree of differentiation is smaller.In summary result of study infers this plant of micro- spore
Worm and nosema locustae are to belong to xenogenesis microsporidian.
The feature of isolated microsporidian: (1) the cluster difference that small unit rDNA sequence and other micro- spores belong to is less than
10%, it is maximum with the difference of Microsporidium Vairimorpha ceraces (Nosema/Vairimorpha) group, reach 50%;(2) it is living
Shi Zhong, single spore shape have young Spore Stages;(3) morphological feature: there is development schizont and sporont body in (i)
(meront/sporont) there is electron dense object in the stage in core;(ii) spore polar filament circle 3-12;The pole that the micro- spore of locust worm belongs to
Wire ring 3-12;(iii) there is a large amount of vacuole in spore rear end, and the micro- spore category vacuole of locust is few;(iv) epispore contains electron dense
Object;(4) tissue specificity specially parasitizes epithelial cell;Host is Orthoptera locust, scab locust and locust.
It is separated to nosema locustae, after per oral inoculation infects locust, initial stage without obvious external symptom, is developed to the nymph of a locust
Aged or adult stage, disease pest body colour just start to become bronzing from canescence, and serious susceptible polypide pinkiness, abdomen feels like jelly,
Slightly swelling, skin is de- sometimes does not get off, wing shrinkage.Later period disease pest shows hypoevolutism, breeding time extends, the bodily form reduces, last dead
It dies.Spore is only separated to after dissection out of fat-body.It can be seen that microsporidian main infection adipose tissue.Day by day continuous dissection is through connecing
The locust disease pest corpse of kind, 3 ages are inoculated into 5 age in days majorities and separate spore, and 3 ages in days are inoculated into adult stage majority and also separate
To spore.5 ages in days, which are seeded in the adult later period, can see spore.Most started to generate spore earlier than 7-10 days after inoculation, it 2 weeks or so can
See mature spore, spore largely generates within 25 days or so.Mature spore is round, and size is irregular, and mean size is 4.5 × 2.2 μm.
Show that the microsporidian can infect locust, and proliferation generates a large amount of spores in vivo at it.Originally locust proliferation host is single in the early stage
Head sporulation quantity is not high, but is directed to its multiplication characteristic, when by finding out suitable cause of disease inoculum density, host insect age and harvest
Between after, single head sporulation quantity can be made to be increased to 6 × 109It is more than a spore.Using 30cm × 40cm × 50cm insect cage single cage
500-700 head can be supported, 20 rearging cages can raise locust 10000-140000 head, and average single head spore output is by 4 × 109A spore
Son is increased to 6 × 109A spore.
By aforementioned present invention inventor nosema locustae isolated from Asiatic migratory locust, 10 are reached in locust body
Then Dai Hou reached for 10 generations using culture medium in vitro culture, obtained nosema locustae is named as XJ-20, and classification naming is
Nosema locustae (Nosema locustae), is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms
The heart, the preservation time is: on November 3rd, 2015, preservation address are the Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese Academy of Sciences
Institute of microbiology, deposit number CGMCC No11170.
Whether meet locust spore with the composition that culture medium culture in vitro culture nosema locustae depends on appropriate media
The history of life different developmental phases requirement of sub- worm.
After nosema locustae after separation reaches 10 generations, identification in locust body, synthesis and selection are suitable for culture
Base is packed into culture bottle or bioreactor, cultivates 30-50 days, micro- spore count is made to reach certain amount, and then dilution continues to cultivate,
To reach requirement concentration.
Further, the invention also provides the nosema locustaes to prepare the purposes in biological insecticides.
There is provided one kind can cultivate the culture medium and method of nosema locustae in vitro for another aspect of the present invention,
Enable microsporidian the surface of culture vessel complete its history of life go forward side by side line splitting proliferation, and then reach breeding proliferation mesh
's.
Inventor is examined by the history of life each step to microsporidian and analysis, selects and adjust culture medium
Composition proposes the culture medium for microsporidian in vitro culture, wherein reagent is supplemented containing certain protein extracts and viscosity,
To be suitble to nosema locustae to complete the history of life and culture.
Inventor's detection and analysis different extracellular matrixes coated cell culture vessel is if appropriate for microsporidian
The history of life and proliferation, as a result, it has been found that when the chitin of culture vessel pan coating insect source property, water solubility, deacetylation, enhancing
Adhesiveness of micro- spore on culture vessel surface, and the division growth of micro- spore can be promoted.
Therefore, on the basis of the studies above, the invention proposes a kind of for cultivating the culture medium of nosema locustae,
The culture medium includes:
1) or mixtures thereof or mixtures thereof or mixtures thereof inorganic salts, sugar, amino acid and or mixtures thereof vitamin;
2) as the insect source property of extracellular matrix, water solubility, deacetylation chitin;
3) protein extract;And
4) as the polyvinylpyrrolidone of visco-supplement, preferably PVP K-90;
Each ingredient is substantially soluble in pure water, adjusting Medium's PH Value is 6.0-7.0, preferably 6.2-6.5, after aseptic filtration
To obtain the final product;
Wherein, the insect source property, water solubility, deacetylation chitin content be 0.01-10g/L culture medium,
It is more preferably 0.1-10g/L culture medium, most preferably 1-10g/L culture medium;
Wherein, the protein extract includes lactoalbumin hydrolysate, yeast extract and tryptosePhosphate broth,
Its content is 500-3000mg/L culture medium, and more preferably content is 1000-3000mg/L culture medium, and most preferred content is
1000-2000mg/L culture medium;
Wherein, the content of the polyvinylpyrrolidone is 100-1000mg/L culture medium, is more preferably 100-
500mg/L culture medium, most preferably 200-500mg/1L culture medium.
In the present invention, insect source property, water-soluble chitin (hereinafter referred to as water-soluble chitin), have carried out removing acetyl
The unique modification changed.The desirable any insect of the chitin, preferably locust slough off the skin fallen.
According to the present invention, the water-soluble chitin has following several acquisition patterns:
For prepare as extracellular matrix the insect source property used, water solubility, deacetylation chitin, selection hydrophily
Chitin, preferably interior surface area be 180m2/ g or bigger chitin.The chitin extracted from locust husking has compared with imperial palace
Portion's area and highly endothermic property.Therefore locust husking, particularly oriental migratory locust husking can be used as extracellular matrix use.
The skin fallen is sloughed off with 1N salt acid soak locust, in the environment for having nitrogen, 100 DEG C are handled 20 minutes.Then salt is outwelled
Acid, with 1N sodium hydroxide solution, 80 DEG C of processing remove protein in 36 hours, chitin or chitin shell are made.It is water-soluble for preparation
Chitin, at room temperature with aqueous slkali dissolve chitin, high viscosity alkali chitin aqueous solution places at room temperature long-time make with
Machine removes acetyl group, and when deacetylation reaches 45-55%, obtained deacetylation is dissolved in water up to chitin (i.e. chitosan).
Above-mentioned water-soluble chitin alkali or acid processing can remove acetyl group, be related to heating.Some reactions can also be used
As Clemmenssen reduction reaction removes acetyl group.The present invention preferably uses a certain concentration alkali process, and guarantees only to remove acetyl
Change modification, without other such as methylolation, the chemical modification of tosylation.Deacetylation is in uniform soluble alkali soluble
It is carried out in liquid.It takes the above method that deacetylation is made to reach 40-60%, preferably 45-50% and chitin and water is made to have height affine
Power.
The insect source water solubility chitin of acquisition passes through unique chemical modification deacetylation, the chitin containing 40-60%
Matter has 40-60% chitosan structure.In other words, water solubility chitin in insect source modifies deacetylation pair by sole chemical
Water has high affinity, and 40-60% is chitin, and 40-60% is chitosan.Since nosema locustae surface has negative electricity
Lotus, microsporidian can be adsorbed on the enterprising line splitting of chitosan positive charge amino and duplication.
Wherein there are two types of the application methods of water-soluble chitin:
1, obtained water-soluble chitin is dissolved in water by 0.01-10g/L, pours in vitro culture vessel into, arrive coating micro-
The culture face of sporozoite, naturally dry.Then the other compositions being added in culture medium of the present invention are used for microsporidian culture;At this
In invention, 0.5 milliliter of chitin aqueous solution coated cell culture bottle surface area is preferably 200 square millimeters.
2, obtained water-soluble chitin is dissolved in culture medium by 0.01-10g/L, by the culture containing water-soluble chitin
Base is added in vitro culture vessel for microsporidian culture.
In the present invention, microsporidian in vitro culture vessel include Tissue Culture Flask, rolling bottle, culture dish, culture dish, culture
Vessel surface is coated with water-soluble chitin, and being sticked on Tissue Culture Flask by water-soluble chitin microsporidian can be grown
And division.
In the present invention, it is preferred to, the protein extract further comprises myosin, cromoci, creatinine
And bovine plasma albumin V;
Wherein, the content of myosin is 1-100mg/L culture medium, is more preferably 1-50mg/L culture medium, most preferably
5-15mg/L culture medium;The content of cromoci is 1-500mg/1 culture medium, is more preferably 1-100mg/L culture medium, optimal
It is selected as 10-100mg/L culture medium;The content of creatinine is 1-500mg/L culture medium, is more preferably 1-200mg/L culture medium, optimal
It is selected as 10-200mg/L culture medium;The content of bovine plasma albumin V is 1000-10000mg/L culture medium, is more preferably 100-
10000mg/L culture medium, most preferably 1000-10000mg/1L culture medium.
In the present invention, it is preferred to, or mixtures thereof or mixtures thereof described inorganic salts, sugar, amino acid or its mixing
It is thin that or mixtures thereof object and vitamin derive from the known inorganic salts being commercially available, sugar, amino acid, the insect of vitamin content
Born of the same parents' culture medium is added 2) -4 on this basis) in component.
In the present invention, it is preferred to, it include NaH in or mixtures thereof described inorganic salts2PO4·2H2O, NaHCO3,
KCl, CaCl2·2H2O, CuCl2·H2O, CoCl2·6H2O, FeSO4·7H2O, MgCl2·4H2O, MgSO4·7H2O,
MnCl2·4H2O, NaCl, NaH2PO4·4H2O, (NH4)6(Mo7O24) 4H2O and ZnCl2Middle one or more;
It include D-Glucose, fructose, sucrose, malic acid, alpha-KG, amber in or mixtures thereof described sugar
Acid, one or more of fumaric acid and maltose;
In or mixtures thereof described amino acid include L-alpha- alanine, beta- alanine, L- R-gene,
Altheine, L-Aspartic acid, L-cysteine, Pidolidone, L-Glutamine, glycine, L-Histidine, the different bright ammonia of L-
Acid, L-Leu, l-cysteine disodium, L- hydroxyproline, l-Lysine hydrochloride, l-methionine, L-phenylalanine, L- dried meat ammonia
Acid, DL-tryptophan, L-threonine, L-Trp, l-tyrosine, l-tyrosine disodium, in Valine and L-Histidine
It is one or more kinds of;
It include biotin, D-VB5 calcium, choline chloride, folic acid, I- inositol, cigarette in or mixtures thereof described vitamin
Acid, puridoxine hydrochloride, riboflavin, thiamine hydrochloride, one or more of vitamin B12 and p-aminobenzoic acid.
In the present invention, it is preferred to, it is 10-30% (v/ that volumn concentration is further comprised in the culture medium
V) animal blood serum, the animal blood serum are fetal calf serum or locust lymph.
In the present invention, it is preferred to, the culture medium contains following component:
1) insect source property, water solubility, deacetylation chitin 10g/L;
2) protein extract:
Include lactoalbumin hydrolysate 1500mg/L, yeast extract 1500mg/L, trypsasePhosphate broth 1500mg/
L, myosin 10mg/L, cromoci 50mg/L, inosine 100mg/L and bovine serum albumin(BSA) V 5000mg/L;
3) viscosity replenishers PVP K-90 250mg/L;
4) inorganic salt mixt:
Include NaH2PO4·2H2O 507mg/L;NaHCO3300mg/L;KCl 1720mg/L;CaCl2·2H2O
750mg/L;CuCl2·H2O 0.1mg/L;CoCl2·6H2O 0.03mg/L;FeSO4·7H2O 0.28mg/L;MgCl2·4H2O
1140mg/L;MgSO4·7H2O 3269mg/L;MnCl2·4H2O 0.01mg/L;NaCl 1425mg/L;NaH2PO4·4H2O
580mg/L;(NH4)6(Mo7O24)·4H2O 0.02mg/L and ZnCl20.02mg/L;
5) sugared mixture:
Include D-Glucose 2917mg/L;Fructose 20.9mg/L;Sucrose 11865mg/L;Malic acid 306mg/L;alpha-
Ketoglutaric acid 169mg/L;Succinic acid 27.4mg/L;Fumaric acid 25.2mg/L;Maltose 500mg/L;
6) ispol:
Include L-alpha- alanine 131.5mg/L;Beta- alanine 234mg/L;L- R-gene 692mg/L;L-
Asparagine 797mg/L;L-Aspartic acid 797mg/L;L-cysteine 10.5mg/L;Pidolidone 1000mg/L;L- paddy ammonia
Amide 750mg/L;Glycine 371mg/L;L-Histidine 1142mg/L;L-Isoleucine 396mg/L;L-Leu 157mg/L;
L-cysteine disodium 60mg/L;L- hydroxyproline 400mg/L;L-Lysine hydrochloride 610mg/L;L-methionine 521mg/L;L-
Phenylalanine 562mg/L, L-PROLINE 396mg/L;DL-tryptophan 559mg/L;L-threonine 173mg/L;L-Trp
91.5mg/L, l-tyrosine 21mg/L;L-tyrosine disodium, 180mg/L;Valine, 292mg/L and L-Histidine
1142mg/L;
7) vitamin mixtures:
Include biotin 0.123mg/L;D-VB5 calcium 0.89mg/L;Choline chloride 10.85mg/L;Folic acid 0.125mg/L;
I- inositol 0.285mg/L;Niacin 0.165mg/L;Puridoxine hydrochloride 0.285mg/L;Riboflavin 0.125mg/L;Thiamine hydrochloride
0.125mg/L;Vitamin B12 0.12mg/L and p-aminobenzoic acid 0.245mg/L;
8) fetal calf serum that volumn concentration is 20% or 30%;
Adjust medium pH to 6.3, after aseptic filtration to obtain the final product.
In the present invention, the lactoalbumin hydrolysate, yeast extract, phosphoric acid tryptoseMeat soup can be from Difco company
Purchase obtains.Myosin comes from fetal calf serum, and cromoci comes from horse liver, can buy from Sigma company.Known inorganic salts,
Sugar, amino acid, vitamin content insect cell medium can be bought from commercial company, and the above composition is added.
Studies have shown that culture medium of the invention can cultivate nosema locustae, it is particularly suitable for embryonic tissue, the fat of locust
Body tissue, reproduction or ovary tissue and digestive system tissue, these are that nosema locustae completes history of life and rich in
Tissue, thus the breeding micro- spore of locust can be cultivated with the liquid nutritional environment of culture medium simulation locust tissue, cell development.
It is another aspect of the present invention to provide a kind of suspension culture methods of nosema locustae comprising following steps:
(1) the described in any item culture mediums of claim 2-7 are added into bioreactor, are then added under drying regime
The microcarrier that average diameter is 50-300 μm, the starting final concentration of microcarrier reach 0.1-3g/L;
(2) in the culture medium containing microcarrier obtained to step (1), nosema locustae is added, the locust is micro-
Sporozoite is named as XJ-20, is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, and deposit number is
CGMCC No.11170;
(3) control parameter pH 7.0-7.2, PO are adjusted2It is 25%, temperature is 28-30 DEG C, maintains to carry out not less than 40rpm
Stirring, changed liquid with the culture medium in fresh step (1) every 10 days;
(4) at the 50th day of culture, after microcarrier sedimentation separation, the lemon containing trypsase is added into the culture solution of retention
Lemon acid sodium solution, is slightly agitated for, and confirms the case where sporozoite is detached from microcarrier every 15-30 minutes microscopically observations, uses pancreas
Enzyme inhibit liquid terminate reaction to get;
Wherein, it is preferred that the volume of culture bioreactor is 3-30L, preferably 10L.
The micro- spore of separated locust is passed on by breeding with locust, and sterile working separates micro- spore, is added and this hair is housed
The Tissue Culture Flask of bright culture medium, condition of culture are 28-30 DEG C of temperature, and incubation time is 50 days, during which complete division growth
Microsporidian moves into the new culture medium Tissue Culture Flask subculture of the present invention that is equipped with and expands.Pass through culture and subculture, micro- spore
Borer population mesh is continuously increased.Microsporidian number through microcarrier suspension culture can reach 60 times of starting culture.
Detailed description of the invention
Fig. 1 is different operating volume bioreactor culture microsporidian growth curve.
Specific embodiment
The invention will now be further described with reference to specific embodiments, the advantages and features of the present invention will be with description and
It is apparent.But examples are merely exemplary, and it is not intended to limit the scope of the present invention in any way.Those skilled in the art answer
It should be appreciated that without departing from the spirit and scope of the invention can details to technical solution of the present invention and form repair
Change or replace, but these modifications and replacement are fallen within the protection scope of the present invention.
The separation of 1 nosema locustae of embodiment and Preliminary Identification
1 materials and methods
The separation and purifying of 1.1 microsporidians
Field Asiatic migratory locust microsporidian is obtained from the separation of Altay Prefecture of Xinjiang Uygur Autonomous Regions Burqin County, is tested
The 3 age in days nymphs of a locust (n=50) of room raising, mix a small amount of wheat bran as feed, by micro- spore of separation using maize leaves by 30 ± 1 DEG C of room temperature
Spore suspension is made in sub- insect infection tissue homogenate, and the microsporidian of suspension, every feeding 10 are counted with blood cell counting plate5Or 107
Spore is applied in maize leaves, and the 4-5 age nymph of a locust is fed after drying.After feeding 24 hours, fresh corn leaf is replaced.Disease pest raising exists
Equipped with 4 watts of fluorescent lamps, illumination round the clock, in the transfer room that temperature is 30 ± 1 DEG C.It is developed to the aged or adult stage to the nymph of a locust, collects
It dies of illness worm corpse, appropriate distilled water is added and smashs to pieces, differential centrifugation obtains precipitating spore.Spore is resuspended in distilled water, be placed in-
It is saved backup in 20 DEG C of refrigerators.
The nymph of a locust is squeezed with phosphate buffer (Phosphate-buffered saline, PBS), and 2 milliliters of suspensions is taken to be put into
2 milliliters containing 25%, 50%, on the PBS gradient liquid of 75%Percoll, 2000g is centrifuged 30min, from the low collection sporozoite of pipe,
PBS centrifuge washing is used repeatedly, is put into sterile distilled water, and homogeneous liquid is filtered with adsorption cotton, and 900g is centrifuged 5 minutes, repeatedly with distillation
Water centrifuge washing.
The size and form of 1.2 microsporidians are observed
Nosema locustae is purchased from U.S. M&R Durango company.Locust sample is derived from the pasture of Xinjiang region in 2013, sample
This number n=315, abdominal incision remove tissue and organ sample.
It is observed under phase contrast microscope.The fresh locust for removing tissue and organ is homogenized with dismembyator, detects whether to infect
Or it is prepared into the microsporidian suspension of transfection.Fresh micro- spore suspension can also be prepared from the excrement of the locust of suspected infection.This
Two kinds of suspensions can directly be observed under the microscope with distilled water or the mixing of Ringer ' the s solution of 1/4 ionic strength, it is also possible to first
Alcohol is fixed, Jim Sha dyes or CalcoXuor White M2R is dyed or CalcoXuor and DAPI double staining observation core.
To carry out projection Electronic Speculum observation, it is solid that infected tissue 2.5% (V/V) glutaraldehyde and 0.1M can block 4 DEG C of sour (pH7.4)
Fixed 1 hour, then with 1.% (W/V) OsO4After fixation, 1% acetic acid uranium dyeing, sample is embedded in Spurr ' s resin, uses concentration
Incremental acetone dehydration.For pathological observation, 0.5-1 μm of slice is placed in slide, micro- with Nikon E-600 with methylene blue staining
Sem observation.Projection Electronic Speculum observation is such as carried out, ultra-thin section is dyed with lead citrate, with H -300 Hitachi and JEM 100CX
Microscope is observed in 80-100kV.
The measurement of the serological relation of 1.3 microsporidians and nosema locustae
Monoclonal antibody coated colloid pearl M11 and M12 are purchased from Tokyo Yakult company.8 microlitres of colloid pearls and 8 micro-
It rises spore suspension mixing to drip in slide hole, 2 control slides are containing only spore liquid and coating pearl.When 50% spore absorption pearl is aggregated into
Block is then the positive.90% spore does not adsorb pearl, then is feminine gender.
It is 1 × 10 that nosema locustae, which is diluted to concentration with 9g/L NaCl solution,9The spore liquid of a/mL, Freund are complete
The complete immune male rabbit of adjuvant injection, 1 × 109A/mL spore liquid adds incomplete Freund's adjuvant each after first time is 2,3 weeks immune
Booster immunization is primary, takes blood to produce Nb immune antiboidy serum after finally immune 1 week.1 is pressed with 9g/L NaCl solution when test:
The dilution of 32 volume ratios.The spore liquid of 1 plant of microsporidian and anti-Nb serum are subjected to serological reaction with slide agglutination, observation is solidifying
Poly- response situation, while negative control is made with normal rabbit serum.
The history of life of 1.4 microsporidians observes and infection locust
The susceptible nymph of a locust of inoculation 15-20 days is taken, dissection takes out fritter fat-body, is applied on cover plate, is fixed with 95% methanol,
Jim Sha dyeing, om observation.The spore of purification is diluted to 1 × 108Spore/mL, drop are consolidated on cover plate with 25% glutaraldehyde
It is fixed, ethanol series dehydration, metal spraying, the film making of H600 (Hitachi, Tokyo, Japan) scanning electron microscopic observation.Take susceptible later period rouge
Fat tissue is starved acid pair with glutaraldehyde one and is fixed, epoxy resin embedding, L K B ultrasound slice machine-cut piece, one citric acid of acetic acid uranium
The double dyeing of lead, the film making of AE1EM-801 transmission electron microscope observing.
Spore liquid is diluted to l x 107Spore/milliliter feeds the 2-5 age in days nymph of a locust, every group processing 30, counts day by day
It dies of illness borer population, then the worm corpse that will die of illness is smashed to pieces respectively, hydraulic pressure piece processed, one by one microscopy, having found spore, person is susceptible worm corpse.
Spore measures fixed: extracting spore liquid to every worm corpse of dying of illness, is counted after purification with blood counting chamber.
It is observed with Giemsa staining method.From 5 microsporidians of field Asiatic migratory locust and the development of nosema locustae
The history of life.It is inoculated with 1 plant of field Asiatic migratory locust microsporidian with 2 age of the day Asiatic migrotory locust nymph of a locust, after different time takes middle intestines after infection
Portion's tissue smear fixes 3min with 95% methanol, and Giemsa dyes 10min, and oil under the microscope, is taken pictures.
The Molecular Phylogeny of 1.6 field Asiatic migratory locust microsporidians is analyzed
1.6.1 prepared by sporozoite DNA
Containing 5 × 106Spore suspension 900g is centrifuged 2min, and precipitating is resuspended in 5 μ l distilled water and 200 μ l of STE liquid
In (100mM NaCl, 100mM Tris-HCl, pH 8.0,1mM EDTA), be vortexed concussion, and 800g is centrifuged 1min.Precipitating is used
150mg bead (Sigma G-8772,425-600 μ m diameters) and 150 μ l STE liquid, which are vortexed, to be shaken 30 seconds, and 2 microlitres of addition is dense
10 milligrams/ml Proteinase K Solution is spent, 55 DEG C are incubated for 2 hours, are put into 95 DEG C of incubation 5min, are put into centrifuge tube 17,500g centrifugation
2min, 10 times of volume supernatants are added 1 times of volume 3M sodium acetate, ethyl alcohol/phenol chloroform, ethanol precipitation DNA, are floated again with ethyl alcohol
It washes, is dissolved in TE buffer (10mM Tris-HCl, pH 8.0,1mM EDTA).
1.6.2 sporozoite PCR amplification SSU rRNA
Primer:
(1) KAI-01=5 '-GAATTCAAGCTTGTAGTAGAGACCCAAATATC-3 ' and KAI-02=5 '-
GAGCTCGCATGCACTGTTCAGATATGGTCCTTATCG-3’
(2) VN001F=5 '-CTGCAGGTACCACCAGGTTGATTCTGCCTGAC-3 ' and VN001R=5 '
GAGCTCGCATGCGGTTTACCTTGTTACGACTT-3 ',
KAI-01 and KAI-02 is sporozoite little subunit rRNA primer (small subunit rRNA, SSUrRNA).
VN001F and VN001R is SSU rRNA conserved sequence primer.100 microlitres of PCR reaction volume, contain respective primer 5pm, 0.2mM is each
DNTP, 2.5 unit Taq DNA polymerases, 10ng DNA profiling, PCR buffer (10mM Tris-HCl, pH 8.4,50mM
KCl、1.5mM Mg Cl2), mineral oil closing is instilled, in thermal cycler (Astec, Program Temp Control System
PC-700 40 circular responses, reaction condition: 94 DEG C of 1min, 55 DEG C of 2min, 72 DEG C of 30s) are carried out.
3- μ l PCR product is mixed with 5 μ l TE, 2 μ the l 40% sucrose liquid containing 0.5% bromophenol blue, and 0.7% agarose is added
Gel electrophoresis, DNA marker (being purchased from treasured biology Takara Shuzo Co company) while electrophoresis.Running gel ethidium bromide staining.
With primer I LSUF (5'-TGGGTTTAGACCGTCGTGAG-3') and S33R (5'-
ATATAGCGTCTACGTCAGGCAG-3' it) is used for the amplification of microsporidian rRNAITS sequence, reaction system to be 25 μ L.React item
Part are as follows: 94 DEG C initial denaturation 8 minutes, 94 DEG C 1 minute, 56 DEG C of minutes, 72 DEG C 1 minute, recycle 30 times;72 DEG C extend 10 minutes.
1.5% agarose gel electrophoresis detects PCR product.By 1 plant of field Asiatic migratory locust microsporidian SSU rRNA sequence and rRNA
The PCR product of ITS sequence send Dalian treasured biotechnology Services Co., Ltd to be sequenced.
1.6.3 sporozoite SSU rRNA is sequenced
Micro- spore of -20 DEG C of storages contains 108Spore/ml melts and moves into the micro- from pipe of 1.5-ml, is added
150 μ LTAE (40mM Tris-acetate, 2mM EDTA) are resuspended, and are added 150mg bead (0.5mm diameter),
50s is shaken in bead oscillator (being purchased from U.S. Biospec company), 3min is heated, takes 1-5 μ L as the template of standard PCR.
16S rRNA gene V1f and 1492r primer amplification.Amplification condition: 94 DEG C of denaturation 3min, 35 circulations: 94 DEG C of 45s, 45 DEG C
30s, 72 DEG C of 90s.72 DEG C extend 5 minutes.Separation PCR product is sequenced.
V1f(18f)(5'-CAC CAG GTT GAT TCT GCC TGAC-3');1492r(5'-GGTTAC CTT
GTTACG ACT T-3');350f(5'-CCA AGG A(T/C)GGCAGCAGGCGCG AAA-3');350r(5'-
TTTCGCGCCTGCTGCC(G/A)TCCTTG-3');530f(5'-GTGCCAGC(C/A)GCCGCGG-3');530r(5'-
CCGCGGC(T/G)G CTGGCAC-3');1047r(5'-AACGGCCATGCACCAC-3');1061f(5'-GGTGGT
GCATGG CCG-3 ') or more PCR product splices on DNA sequence analysis software, obtain SSU rDNA whole genome sequence.
1.6.4 Phylogenetic Analysis
To separate N.locustae (AY305324) that microsporidian SSU rRNA gene order and gene pool log in,
N.whitei(AY305323、)Antonospora scoticae(AF024655)、Vairimorpha necatrix
(Y00266) sequence is compared, and constructs various Wild insects with the ortho position connected (Neighbor-Joining) of 5 software of MEGA
The phylogenetic tree of microsporidian SSU rRNA.It uses SSU rRNA gene order as outer group, carries out 1000 repetitions, then distinguish
By the SSU rRNA gene order for separating microsporidian and rRNA ITS gene order and the homeologous sequence downloaded from NCBI
Column carry out similitude and degree of differentiation analysis.
2 results
Fat-body is primary infection site, can also be found in female, male gonad, haemocyte, can also be seen in cavum pericardiale
Observe microsporidian.In the microsporidian history of life, there are many conditions with Host cellular response, from the schizont phase to spore shape
At microvesicle, host's endoplasmic reticulum cisterna, mitochondria and helminth are close.In the schizont phase, it is seen that host's micro-pipe group and helminth matter
Film is connected.When entering for the second schizont phase, there is " tubular structure " in host cell matter.In the schizont phase, helminth (spore)
Massive duplication cause host cell volume reduce and core atrophy.Cause from the conversion of schizont phase to spore phase, sporogenesis
Adipose tissue carries out formula damage, and last fat-body is replaced by a large amount of spores.
2.1 separation microsporidian forms, growth course and ultra microstructure
In Xinjiang region, 2011-2014 has collected 592 locust nymphs of a locust, and prevalence rate in 2011 is 80.6% (n=
151);Prevalence rate 70% (n=40) in 2012;Prevalence rate 53.8% (n=300) in 2013;Prevalence rate 58.8% in 2014
(n=101);Microsporidian is largely present in the excrement of infection locust.
These microsporidian spores and nosema locustae refractivity having the same, but Spore shapes are partially long, in length
Oval, with nosema locustae no significant difference.Separate microsporidian each stage of the history of life of enteral in locust
Form is essentially identical, and development almost synchronizes: visible spherical double-core schizont after infection 20h, schizont is in a manner of binary fission later
Proliferation, 48-72h are division animated period, and schizont splits into spore bud mother cell, and spore bud mother cell binary fission generates 2 pairs
Core spore bud eventually forms the mature spore of 2 double-cores.The growth cycle of this plant of Asiatic migratory locust microsporidian is 96h or so, than
The growth cycle (84h) of nosema locustae is slightly long, and development models meet the feature of Nosema category.
In infection locust larva smear, mainly circular dicaryotic phase spore.Oval, Fresh spores size 4.5 ±
0.16 2.2 ± 0.07 μm of μ m (average ± SE, n=10), methanol is fixed and Jim Sha dyes 4.3 ± 0.20 μ of spore size
M × 2.00 ± 05 μm (n=10).Smear sloughs polar filament, 200 μm of maximum length for sloughing pole pipe.DAPI dyeing illustrates spore
The arrangement of son and archespore body center.In the spore that the painting on piece of Jim Sha dyeing is mostly double-core period, there are the 4 pairs of cores not divided
Spore accidentally has the biggish nucleus of density, 2 cores or the spore of 4 core phases.The difference of spore mother cell and spore is greatly
Small, spore mother cell is longer.
Electronic Speculum observation separation spore, spore are round or oval cell in the puberty, and diameter is 4.4 ± 0.18 μm of (n=
13) (thickness 7-9nm) usually, is wrapped up by single cytoplasma membrane in budding spore, as the spore in other periods,
With the upright contact of host cell.Schizont (meront) cytoplasm contains many ribosomes and several rough surfaced endoplasmic reticulum (RER) cisternas, seemingly
Extend from perinuclear space.Intermitotic double-core has uniform caryoplasm, and has nucleopore on nuclear membrane.The schizont puberty
(Merogony) be separation the spore history of life in mainly proliferation or breeding period.Before spore cell division, schizont is elongated, in core
Occurs microtublue organizing center (MTOC) (coniform spot on film.Two core spore cell chromosome numbers are no more than 8.Since nuclear fission is later than
Cytokinesis, so common the spore for having double-core can be elongated.
It is mainly vacuole, the membranous system containing electron-dense substance and folding in cytoplasm in sporozoite.In sporinite
Inside there is simple plasma membrane and has the early stage spore of surface coat.Coloring matter of the core containing single density has electronics close in division
Spend spiral plaque.Spore mother cell is rounded to contain a large amount of endoplasmic reticulum vacuoles.Spore mother cell has 2 kinds of rows with the spore of pole pipe
Column.There is 3-12 polar filament circle on some irregular clusters, shown on section " fibril " of 20 length, some spore mother cells are containing single
One 16 polar filament circles.Rare in the 4 core spores of division stage, dicaryotic phase spore is in the great majority.Cytoplasm divides immediately after disclosing core separation
It splits.Quantum splitting body spore it is extracellular be spherical shape, in oblong intracellular, it is indicated that division zygoblast plasma membrane plasticity.Quantum splitting
Body spore cytoplasm inhomogenous can dye, sometimes dyeing weight, and dyeing is light sometimes.With in the limpid region of cytoplasm, it is shown as compression
The linear mystery of red dot or chromosome assembling.
There are 2 nucleus in the middle part of spore, two sides are endoplasmic reticulum.Pole spore after spore rear end has one, spore front end pole
There are the multilayer membrane structure of referred to as polar body in silk two sides.The spore for much discharging polar filament can be observed in just dead polypide internal control
Son.Polar filament is routed up from spore one end, and length is 120-130 microns, and there are a fritter sporoplasm in many polar filament front ends.
The internal structure of the microsporidian of transmission electron microscope observation separation has edge as nosema locustae
The double-core of y direction arrangement, conidial cell wall constitutes by 3 layers, is followed successively by outer wall, inner wall and plasmalemma from outside to inside: outer wall compared with
It is thin, color depth;Inner wall is thicker, accounts for about the 3/4 of conidial cell wall, and coloring is shallow;Plasma membrane layer is thin, color depth.The polar filament circle of each microsporidian
Several and polar filament inclination angle is greater than 30 degree.Polar filament circle number is between 3-12 circle, polar filament inclination angle but its polar filament inclination angle 60-70 degree,
With locust sporozoite without significant difference.
Through gradating, schizont becomes the second schizont.This period is monokaryon, can carry out same spermatium fusion.This
A period could not observe coniform spot and mitosis whether occurs, and spore cell size is identical with schizont, but and fragmentation
Body is had any different, and difference is: (i) has diameter 50-100nm electron dense granules in caryoplasm, originally goes out in dicaryospore cell
Now, all there is particle in monokaryon and dicaryospore after.(ii) a large amount of smooth surfaced endoplasmic reticulum cisternas in spore cell matter, vacuole, thin
Lamella accumulation.Iii) there are the accumulation of blister sample film lamella, diameter 30-60nm near endoplasmic reticulum cisterna.
Close to core, compact arranged small micro-pipe group forms 1-2 orthodrome structure.Small micro-pipe is usually by smooth surfaced endoplasmic reticulum packet
It wraps up in.This period all schizonts undergo cell division, and the cell and sporonin not exclusively divided contains 2-4 monokaryon, rather than double
Times core.Nuclear membrane boundary is unclear, also without conical spot, also without micro-pipe and chromosome.Once in a while it can be observed that internally positioned ribosomes
With endoplasmic reticulum cisterna.The plasma membrane thickness about 10-12nm of transition phase has less regular Eversible structure, originally observes plasma membrane appearance
Face electron dense is irregular " patch ", and the rear electron dense substances film that formed wraps up parasitic animal and plant cell, this is meaned turns to the spore phase
Change.Spore mother cell's (Sporonts) size is 4.73 ± 0.17 × 3.56 ± 0.19 μm (n=12), and film is electron dense object
Matter, thickness about 30nm (outer wall), shape, which is elongated, to be extended, and there is the rough surfaced endoplasmic reticulum (RER) of accumulation at two end of cell.The amphiploid ultra micro in the period
Structure is similar with schizont (Meront).Spore mother cell carries out binary fission.
Cell after binary fission is gradually transformed into immature spore.Small micro-pipe group (CSTs, clusters of small
Tubules the major part of cell) is occupied, micro-pipe net junket is finally divided into and forms especially micro- spore across golgiosome.Across Gao Er
The polar tube protein of spore phase is mature on matrix.Immature 2.12 ± 0.08 μm of 5.74 ± 0.14 μ m of spore size (n=5), into one
Step stretches and polarization.Polarization is the vesicles that polar filament top occurs and cell backend electronics densification polar filament object forms, and is immature spore
The feature of sub-district not other period spores.It is a large amount of vacuole, tubular reticulum junket, micro- in addition to polar filament precursor in immature spore cytoplasm
Pipe and the endoplasmic reticulum of extension surround the double-core of central location.Originally, immature sporocyst plasma membrane and electron dense object (outer wall) package.
Immature epispore is multilayered structure, at least three layers in this phase.Prematurity spore feature: reducing suddenly, outer wall and plasma membrane it
Between increase additional layer, there are many tubular structures on outer wall, have Electron-dense body and prematurity pole pipe with reproducibility osmium dyeing rear end
Spiral.The additional layer of mature spore is converted to the terminus spore of electron lucent.
Spore is fixed, is projected under Electronic Speculum, and spore size is 1.43 ± 0.07 μm of 3.3 ± 0.06 μ m (n=10).Electronics is saturating
About 0.3-0.5 μm of bright terminus spore thickness.0.05-0.2 μm of is reduced in spore tip end spore thickness.Outer wall 3-40nm is thick,
Contain an electron lucent layer in two electron density layers.There is the plasma membrane of 10-12nm thickness under outer wall.Sporonin body release, in empty spore
Still contain cytoplasma membrane in film.Multilayered structure is presented in polar filament, and irregular alignment is enclosed at 1-2 layers containing 15-18.Polar filament length is spore
2/5, polar filament and spore long axis oblique angle are 60-70 degree.Pole plastid front end chamber zone contains compact arranged film;Rear end is containing loose
The film of arrangement and rear end is without vacuole.The cytosome of release is circle, is 3 × 6 μm in the size for applying on piece.Have 2 in cytosome
Independent core, cytoplasm electron lucent simultaneously contain circular film.
The serological reaction of 2.2 field Asiatic migratory locust microsporidians
It is negative with anti-SES-NU monoclonal antibody reactive, and M11 and M12 monoclonal antibody reaction negative, the sporozoite less than 10%
Pearl is coated in conjunction with NB monoclonal antibody.The mostly anti-spore reacting positive separated with 18 days nymphs of a locust of infection of locust sporozoite.
Aggregation can be occurred with locust sporozoite antiserum by separating microsporidian, illustrate that they and nosema locustae have
Similar face antigen, it was demonstrated that the affiliation of this plant of field Asiatic migratory locust microsporidian and nosema locustae is close.
The Molecular Phylogeny of 2.3 microsporidians is analyzed
A 1250bp segment is obtained using primer KAI-01 and KAI-02 primer amplification separation microsporidian.Separate spore
SSU rDNA sequence is 1337bp, N.locustae, N.whitei SSU rDNA sequence 1335bp and 1337bp, separates spore
SSU rDNA sequence and N.locustae homology are 95-97%.The G/C content of three sequences is 65%, similar
Antonospora scoticae (62%), but than N.bombycis high (33%).Phylogenetic analysis separation spore,
N.locustae, N.whitei are in together in chadogram, and relationship is still unclear.Parsimony discloses separation spore closest to locust
Worm sporozoite (N.locustae).ML display separation spore and N.whitei are most close, as adjacency analysis structure.All knots
Fruit illustrates to separate spore, N.locustae, N.whitei form with new sister's cluster Antonospora scoticae, and contains
The micro- spore cluster sequence of the locust of N.bombycis is uncorrelated.
Construct this plant of microsporidian SSU rRNA's with ortho position phase connection (Neighbor-Joining) of 5 software of MEGA
Phylogenetic tree.In chadogram, this plant of field Asiatic migratory locust microsporidian is respectively positioned in the monoid of Nosema category, and explanation is
Nosema belongs to microsporidian, accordingly names this plant of field Asiatic migratory locust microsporidian for Nosema sp-XJ-10, selection 20
Microsporidian SSU rRNA gene order carries out similitude and Genetic Distance Analysis, finds Nosema sp-XJ-10 and Nosema
Belong to type sepecies nosema locustae (N.locustae, AY305324) have very high similitude, similarity 95%, with
The equal very little of the genetic distance of N.locustae.Therefore illustrate that this field Asiatic migratory locust microsporidian belongs to Nosema category, and
And it is close with the affiliation of nosema locustae (N.locustae).Choose 15 microsporidian rRNA ITS gene orders into
Row similitude and Genetic Distance Analysis find that the similarity of this field Asiatic migratory locust microsporidian and nosema locustae is low
In 75%, degree of differentiation is also larger, illustrates that this Asiatic migratory locust microsporidian is with nosema locustae (N.locustae)
Nosema belongs to not of the same race, is that Nosema belongs to microsporidian not of the same race, with Antonospora scoticae and
The genetic distance of N.bombycis respectively reaches 21.3 and 11.5.Confirmation is microsporidian not of the same race.
Embodiment 2. separates breeding in nosema locustae body
1. material and method
1.1 materials: Nosema sp-XJ-10 is proliferated through Asiatic migratory locust.Xinjiang Uygur Autonomous Regions A Le picks up from locust system
Test worm is done in safe area locust egg, indoor passage raising.
1.2 test method
1.2.1 a large amount of proliferation of the micro- robe worm of locust
1) relationship of host's lethal time and cause of disease stage of development
Microsporidian spore liquid is diluted to 1 × 108Spore/mL takes 10 microlitres of drops on diameter 10mm wheat seeding blade, cool
The locust 4 age nymph of a locust of this room passage raising is fed with after dry, per first, about 10 altogether.For 24 hours afterwards by wheat seeding blade eat everything up
The nymph of a locust is used as test worm, is placed in big plastic barrel and raises, and 30 ± 1, humidity 70%, illumination round the clock, using wheat seeding plus wheat bran as feed, often
Dead borer population is recorded in its observation, collects worm corpse of dying of illness within the 10th day after inoculation, and check in worm corpse of dying of illness under phase contrast microscope
Pathogen developmental state.
2) it is inoculated with the relationship of cause of disease concentration and lethal time and spore output
1×105Spore/mL, 1 × 106Spore/mL, 1 × 107Spore/mL, 1 × 108Spore/mL microsporidian liquid difference
10 microlitres of drops are drawn on wheat seeding blade with micro suction dispenser, and single head is fed with the 4 age nymphs of a locust after airing, and the blade person of eating up is tried
Worm is placed in single head in small plastic barrel and raises.Rearing conditions are with 1), and every processing is inoculated with 20 and is divided into 3 groups, and observation is recorded and died of illness daily
Worm, single head are weighed, and survey spore output with blood counting chamber.
3) relationship in host insect age and lethal time and spore output
2,3,4, the 5 age in days nymphs of a locust are chosen, single head is fed with l x106Spore/mL, method with 2), die of illness by daily observation record
Worm, single head are weighed, and spore output is surveyed.
4) relationship of harvest time and spore output
Using l x 106Spore/ml is sprayed on wheat blade, and the 4-5 age in days nymph of a locust is fed with after airing, renews fresh feeding after 24 hours
Material feeding, in rectangle wire gauze insect cage (30cm × 30cm × 50cm), 200-300 head/cage, every batch of 4000, constant temperature 30
± 1 degree Celsius, humidity 70%, illumination round the clock.Worm corpse of dying of illness is collected within 10-40 days, in -20 DEG C of freezer storages.
Extraction of spores: freezing disease pest corpse is pulverized with meat grinder, and differential centrifugation is after the filtering of nylon sand cloth up to thick purification spore
Son counts the purifying infection nymph of a locust phosphate buffer (Phosphate- for surveying spore output microsporidian through blood counting chamber
Buffered saline, PBS) it squeezes, take 2 milliliters of suspensions to be put into 2 milliliters of PBS ladders containing 25%, 50%, 75%Percoll
It spends on liquid, 2000g is centrifuged 30min, from the low collection sporozoite of pipe, uses PBS centrifuge washing repeatedly, is put into sterile distilled water, homogeneous
Liquid is filtered with adsorption cotton, and 900g is centrifuged 5 minutes, uses distilled water centrifuge washing repeatedly, and -20C is saved.
2 results
Asiatic migratory locust is infected with microsporidian, initial stage catches an illness feature without obvious outside, when the nymph of a locust enters the aged or adult stage
Afterwards, susceptible serious polypide abdomen feels like jelly, swelling, is in bronzing;Skin is de- not to be got off or dies of the skin taken off to slough off interior, wing shrinkage,
Puberty is spun out, last dead.Strong worm fat-body yellow transparent, piece volt, diease occurrence fat-body then become opaque, are creamy white,
It is filled with a large amount of spores.
The 2 age nymphs of a locust are inoculated with microsporidian, before most of individuals died of for 5 ages.After the inoculation of the 3 age nymphs of a locust, then there are a small number of individuals can
Develop adult.4-5, it is most of after the inoculation of the age nymph of a locust to develop to adult, but become adult in spite of illness more.
The 4 age nymphs of a locust are fed with the microsporidian of various concentration, occurred mature spore in pin main body through 10-15 days.25-30
Its visible a large amount of spore generates.Single head locust can produce 4x l09Spore.Show nosema locustae Nosema sp-XJ-10
It can be proliferated in locust body, generate a large amount of spores.
Multiplication characteristic of 2.1 microsporidians in group breeding locust
2.1.1 the relationship of host's lethal time and cause of disease stage of development
The 4 age in days nymphs of a locust are inoculated with l x l06It is all dead after spore/head 28 days.Start within the 10th day after inoculation to receive the worm that dies of illness, altogether
79 are received, wherein accounting for the 48.1% of total dead worm corpse dead 38 before 16 days, microscopy cause of disease is in schizogamy period,
Spore is few or immature.The 18-22 days dead worm corpse 15, account for 19.0%, all maturation spores, schizont and not at
Ripe spore is few.It can be seen that it is few to generate robe amount in schizogamy period for cause of disease many places in Early death worm corpse, and disease pest is dead
Time delays, and the cause of disease generated in vivo is then in the spore maturity period, and it is more to generate spore amount.
2.1.2 it is inoculated with the relationship of cause of disease concentration and lethal time and spore output
It is inoculated with 1x 106-1×108Spore/head, the trend that average single head sporulation quantity increases with the reduction of inoculation cause of disease concentration.
It is lower to be inoculated with cause of disease concentration, it is 12.6-34.5 days from the median lethal time that the median lethal time is also longer, inoculum density and cause
Dead time is negatively correlated (r=0.9121).Lethal time is drawn longer, and polypide weight also increases, and 0.54-2.01 grams of average weight/
Head, the two are positively correlated (r=0.9021), and within the scope of certain lethal time (11.1 1 21.2 days), polypide weight is produced with spore
Amount is positively correlated (r=0.9657).Therefore inoculum density influences host's lethal time, thus influences to produce the amount of embracing, the present embodiment knot
Fruit shows that inoculum density is l x l06A spore/ml can obtain higher sporulation quantity.2-4 days different worms are inoculated with identical spore liquid
In age, average single head, which produces full measure, to be had the tendency that increasing with worm age and increase.Worm age is smaller more sensitive to microsporidian, thus average
Lethal time shortening, weight loss, spore output are also low.Instar on the 5th is due to reducing micro- spore sensibility, although median lethal
Time is elongated, and weight increased, but sporulation quantity declines instead, therefore, selects instar inoculation on the 4th to be easy to get higher spore and produces
Amount.
2.1.3 the relationship of harvest time and spore output
A large amount of proliferation nosema locustaes are when to collect worm corpse of dying of illness be to obtain higher one key factor of spore output.Inspection
Look into two batches different times harvest die of illness worm corpse and measure its produce embrace amount.After inoculation 10-20 days harvest disease pest corpse sporulation quantity compared with
It is low.Higher (4-7 × 10 of sporulation quantity of 20 days or more harvest disease pest corpse9Robe/head), amount highest (5- is embraced in the production of 30-40 days harvests
7×109Spore/head).
2.2 Field information effects
On the grassland of Inner Mongol, continuous 4 years progress small areas of 2011-2015 and large area field trial, as the result is shown not
It is different with spore dosage locust elimination effect, it is higher than 0.65 × 109Full son/mu corrects Revision insect recluced rate up to 60% or so.
3. nosema locustae in-vitro culture medium of embodiment, extracellular matrix prepare and the exoadaptation of nosema locustae
Culture
Pure water is added in 3.1 self-control nosema locustae culture medium MX, volume 1L, following each substance.
Inorganic salt mixt: NaH2PO4·2H2O 507mg/L;NaHCO3300mg/L;KCl 1720mg/L;CaCl2·
2H2O 750mg/L;CuCl2·H2O 0.1mg/L;CoCl2·6H2O 0.03mg/L;FeSO4·7H2O 0.28mg/L;
MgCl2·4H2O 1140mg/L;MgSO4·7H2O 3269mg/L;MnCl2·4H2O 0.01mg/L;NaCl 1425mg/L;
NaH2PO4·4H2O 580mg/L;(NH4)6(Mo7O24) 4H2O 0.02mg/L and ZnCl2 0.02mg/L.
Sugared mixture: D-Glucose 2917mg/L;Fructose 20.9mg/L;Sucrose 11865mg/L;Malic acid 306mg/L;
Alpha-KG 169mg/L;Succinic acid 27.4mg/L;Fumaric acid 25.2mg/L;Maltose 500mg/L.
Ispol: L-alpha- alanine 131.5mg/L;Beta- alanine 234mg/L;L- R-gene
692mg/L;Altheine 797mg/L;L-Aspartic acid 797mg/L;L-cysteine 10.5mg/L;Pidolidone
1000mg/L;L-Glutamine 750mg/L;Glycine 371mg/L;L-Histidine 1142mg/L;L-Isoleucine 396mg/L;
L-Leu 157mg/L;L-cysteine disodium 60mg/L;L- hydroxyproline 400mg/L;L-Lysine hydrochloride 610mg/L;L- first
Methyllanthionine 521mg/L;L-phenylalanine 562mg/L, L-PROLINE 396mg/L;DL-tryptophan 559mg/L;L-threonine
173mg/L;L-Trp 91.5mg/L, l-tyrosine 21mg/L;L-tyrosine disodium, 180mg/L;Valine, 292mg/L
And L-Histidine 1142mg/L.
Vitamin mixtures: biotin 0.123mg/L;D-VB5 calcium 0.89mg/L;Choline chloride 10.85mg/L;Folic acid
0.125mg/L;I- inositol 0.285mg/L;Niacin 0.165mg/L;Puridoxine hydrochloride 0.285mg/L;Riboflavin 0.125mg/L;
Thiamine hydrochloride 0.125mg/L;Vitamin B12 0.12mg/L and p-aminobenzoic acid 0.245mg/L.
Protein extract combination: lactoalbumin hydrolysate 1500mg/L, TC-yeastolate 1500mg/L, trypsasePhosphorus
Hydrochlorate meat soup 1500mg/L, myosin 10mg/L, cromoci 50mg/L, inosine 100mg/L and bovine serum albumin(BSA) V
5000mg/L;
Visco-supplement PVP K-90,250mg/L.
10%, 20% and 30% fetal calf serum is further added, culture medium MX10, MX20 and MX30 culture medium is made.
PH to 6.3 is adjusted with potassium hydroxide, standby make is stored after aseptic filtration.
3.2 insect source property, water solubility, deacetylation chitin preparation
3.2.1 water-soluble chitin is prepared from the husking of locust pupa
(i) preparation process
The container for filling 300mL1N hydrochloric acid is added in the skin that 5 grams of locust pupas are taken off, under filled with nitrogen environment.100 DEG C of heating 20
Minute, vacuum drying neutral with warm water and distilled water flushing.Dry locust pupa back off skin immerse 300 milliliters of 1N sodium hydroxides it is molten
Liquid, the protein that 80 DEG C of heating, stirring remove in husking for 36 hours obtain 0.9 gram of chitin.
(ii) water compatibility is assessed
In saturated solution, relative humidity analyzes chitin after absorbing moisture by each chitin of BET equation indirect determination
Hydrophily.There are a large amount of internal areas and height heat-absorbing due to preparing chitin, chitin has high to water affine
Property.
(iii) chitin deacetylation
The above method prepares 3 grams of chitin 40% sodium hydroxide solutions of addition, 25 DEG C place 70 hours it is uniform to be formed
Solution system.There are about 74% chitin deacetylations.It is detected with infrared spectrometer, deacetylation degree is 45-48%, in room temperature
Under be dissolved in water.Under saturated pressure, deacetylation chitin adsorbs 6.3 times that water exceeds former above-mentioned non-acetylation chitin,
There is high-affinity to water.The micro- spore cell epimatrix of outer locust can be done.
The in vitro culture of 3.3 microsporidians
(1) after the microsporidian Nosema sp-XJ-10 that embodiment 2 is bred takes out, 37 DEG C of water-baths 30 seconds to 1 point are put into
Clock, with sterile Carlson's solution (penicillin 100000U/100mL, 0.05%gentamicin, 0.05%
Antiformin it) washs three times;
(2) it is transferred in 15 milliliters of centrifuge tubes, 1000-1500rpm is centrifuged 10-20 minutes;
(3) supernatant is removed, balanced salt solution is added in precipitating, such as Emhorn liquid or Hank s ' Hank s ' liquid, 1000-
1500rpm is centrifuged 10-15 minutes, and precipitating samples counting containing a large amount of micro- spore.
(4) what is prepared from locust pupa removes acetyl, water-soluble chitin solution containing 10g/L, is applied to culture bottle wall surface, room temperature
It spontaneously dries, is washed with sterile saline secondary.
(5) culture medium MX30 moves into the culture bottle of pan coating chitin, is added final concentration of 1 × 105-1×106/ mL's
Micro- spore carries out static gas wave refrigerator, and 28-30 DEG C of cultivation temperature, CO2 concentration is 3-5%.
(6) after cultivating 10 days, liquid, the fresh training with half volume in the 20th day are changed with the fresh culture MX30 of 1 half volumes
It supports base MX20 and changes liquid, change liquid with the fresh culture MX10 of half volume within the 30th day, microsporidian raised growth is bred after 30 days,
Until 40 days, microsporidian number reached maximum.At 30-40 days, microsporidian was floated from culture surface, can harvest liquid centrifugation
The first generation microsporidian of in vitro culture is obtained, 10% fetal calf serum culture medium is adapted to.It can with this 10% fetal calf serum culture medium
Carry out nosema locustae culture and breeding.
Subculture in vitro separately culture is carried out to nosema locustae Nosema sp-XJ-10 using 10% fetal calf serum culture medium,
The 10th generation nosema locustae that subculture in vitro separately culture is obtained is named as XJ-20, and classification naming is nosema locustae
(Nosema locustae) is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, preservation time
Be: on November 3rd, 2015, preservation address are Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Chinese Academy of Sciences microbe researches
Institute, deposit number CGMCC No11170.
The external shaking flask culture of 4. nosema locustae of embodiment
1. material and method
1.1 microsporidian strains: what embodiment 3 obtained reached for 10 generations in locust body, reached for 10 generations in vitro, is named as
The nosema locustae of Nosema sp-XJ-20 (abbreviation XJ-20), deposit number CGMCC No11170.Culture medium preparation is as implemented
Example 3.
1.2 carry out microsporidian vitro propagation method using shaking flask
(1) the nosema locustae culture medium containing 10% fetal calf serum, the water solubility chitin of acetylation containing 10g/L is prepared
MX10;(2) Nosema sp-XJ-20, inoculum density preferably 1 × 10 are inoculated with5-1×106Spore/mL;(3) condition of culture: culture
28-30 DEG C of temperature, CO2Concentration is 3-5%, incubation time 30-50 days, shaking flask revolving speed 60rpm/min.Every 10 days, measurement
OD600 value and micro- spore count.It is respectively 0.5L, 1.5L using rolling bottle volume.
The nosema locustae culture medium without containing acetylation water solubility chitin is prepared simultaneously as control, remaining ingredient
It is identical as the culture medium in above-mentioned steps (1).
The observation of 1.3 Electronic Speculum
10,20,30,40,50 days in culture are separately sampled, are incubated for 15 at 37 DEG C with 2.5% glutaraldehyde (PBS preparation)
Minute, 4 DEG C are stored 24 hours, are embedded on 1 millimeter long 2% agarose square and are sliced, in 100mM phosphoric acid solution (pH7.4)
It after being fixed with 1% osmium tetroxide, places 1 hour on ice, slice is washed with distilled water, small with the double uranium processing 1 of 1% acetic acid at 4 DEG C
When, ethyl alcohol and embedding are dehydrated in the epoxy, are dyed with 1% uranium acetate, lead citrate solution, Philips CM10 electricity
60kV, 30 microns of aperture observations on mirror.
2. result
2.1 nosema locustae shaking flask cultures
Contain in culture medium and without removing acetyl water solubility chitin culture microsporidian situation such as table 1.Culture 10 days, locust
The density of microsporidian is 1.3 × 106Spore/mL, culture 20 days are 1.4 × 106Spore/mL, culture 30 days are 1.8 × 106Spore
Son/mL, culture 40 days are 2.7 × 106Spore/mL, culture 50 days are 3.6 × 106Spore/mL..Acetyl water is removed compared to being free of
The culture medium of dissolubility chitin increases.And 10-20 days after being inoculated with nymph of a locust feeding breeding microsporidian, the disease pest of harvest
Corpse sporulation quantity is lower.The sporulation quantity of 20 days or more harvest disease pest corpse is higher, reaches 4-7 × 109Robe/head harvests for 30-40 days
Sporulation quantity highest, reaches 5-7 × 109Spore/head.It can be seen that compared to the method for the method bred in vivo, it can using in vitro culture
Disposably obtain greater amount of nosema locustae.
The culture medium (removing acetyl water solubility chitin containing 10g/L) of 1. invention of table and without removing acetyl water solubility chitin
The density (× 10 of culture medium spinner culture microsporidian6Spore/mL)
Embodiment 5 continuously cultivates amplification nosema locustae in single 2L bioreactor
5.1 used materials
Bioreactor: 2.4 liters of working volumes can handle bioreactor, be purchased from Millipore Corp. of the U.S., equipped with pH,
PO2, temp probe and agitating paddle.
3 ball of microcarrier Cytodex that average diameter is 50-300 μm under drying regime is purchased from U.S. GE company, uses phosphorus
It after acid buffer PBS (pH7.4) aquation 24 hours, is washed three times with PBS, after the sterilizing of PBS mesohigh, microsporidian training is added
Nutrient solution makes microballoon stick surface area up to 4400cm2/g。
Microsporidian: nosema locustae XJ-20, deposit number CGMCC No11170.
Culture medium preparation such as embodiment 3.
5.2 originate microcarrier activity and microsporidian protection agent assessments operation sequence during secondary culture
When microsporidian first time secondary culture, it is micro- that very low concentration is assessed using microcarrier concentration 0.1g/L and 0.3g/L
Carrier is to microsporidian growth effect.
Microsporidian is added in the 2L culture medium MX10 (chitin containing deacetylation is shown in embodiment 3) of the microcarrier containing 0.6g
XJ-20 makes its final concentration reach 5.0 × 106Spore/mL imports the first bioreactor (Bio1), makes to stick area after mixing
Reach 25000 spores/cm2, originate microcarrier concentration 0.3g/L.Adjust control parameter pH7.0-7.2, PO2It is 25%, temperature is
28-30℃.Microsporidian XJ-20 is added in microcarrier containing 0.2g, 2L culture medium MX10 (chitin containing deacetylation), makes its end
Concentration reaches 5.0 × 106Spore/mL imports the second bioreactor (Bio 2) after mixing, make to stick area and reach 25000 spores
Son/cm2, originate microcarrier concentration 0.1g/L.Adjust control parameter pH 7.0-7.2, PO2It is 25%, temperature is 28-30 DEG C.
In culture 50 days, microsporidian carries out enzymatic treatment by following procedure: after microcarrier sedimentation separation, bioreactor was about
There is the retention of 300mL culture solution, 0.025M sodium citrate solution (PBS, the not calcium ions of 300mL trypsase containing 600mg are added
And magnesium ion), it is slightly agitated for, actually detaches microcarrier every 15-30 minutes microscopically observation confirmation sporozoites, use 300mL
Pancreatin inhibits liquid (inhibitor containing 1mg/mL is purchased from Sigma Co., USA) to terminate reaction.After microsporidian cell count, remove
Sporozoite suspension is separately added into 2.4g microcarrier (Bio1) or 0.6g microcarrier (Bio2) in 2L bioreactor, adjusts micro-
Spore count, which makes to stick area, reaches 25000/cm2Carry out second of secondary culture.During culture, liquid is changed through 2 times, changes liquid for the first time
Time is the 4-6 hour being added after naked microcarrier, and changing liquid for the second time is the 20th day.The micro- spore of count evaluation after the 50th day harvest
The growing state of worm.The protection of microsporidian is made using same Programmable detection deacetylation chitin and polyvinylpyrrolidone
With.
5.3 appraisal procedures that cow's serum acts on during secondary culture
Program for example above-mentioned 5.2, detection culture medium are 3 culture medium MX10 of embodiment, microcarrier initial concentration 0.3g/L, difference
In the 5th and the 8th day progress trypsin treatment.Microcarrier is washed three times with 600mL washing lotion (PBS) except serum deprivation before enzymatic treatment.
5.4 result
For the effect for assessing microsporidian growth parameter(s), duplicate sample is acquired from bioreactor suspension in certain time, is used
Cell counter detects the microsporidian number of microsporidian concentration, the output of accumulation.
5.4.1 " starting microcarrier concentration " parameter
In continuous microsporidian culture, " starting microcarrier concentration " is that 0.1g/L is minimum, but when microsporidian number is double
Between it is most fast.The microsporidian number of accumulation is all higher in test.When first time secondary culture, when microcarrier concentration is 0.1g/L,
Microsporidian growth is had no adverse effect.In the bioreactor of higher microcarrier concentration, microsporidian growth has active
Self-replacation trend.The results are shown in Table 2:
2. microsporidian of table continuously three times culture in originate microcarrier various concentration effect
5.4.2 " microsporidian protects reagent " parameter
PVP and water-soluble acetylation chitin can increase microsporidian to microcarrier in microsporidian is continuously cultivated
Adhesive attraction.
5.4.3 " serum " parameter
Serum has in microsporidian is continuously cultivated and increases microsporidian to the adhesive attraction of microcarrier and proliferation work
With.
The bioreactor culture nosema locustae of embodiment 6.
6.1 material therefor
Bioreactor: working volume 2L, 5L, 10L bioreactor (German Sartorius product), equipped with pH, pO2,
Temp probe and agitating paddle, remaining material is as embodiment 5.Autoclave sterilization is spare after calibration.
3 ball of microcarrier Cytodex that average diameter is 50-300 μm under drying regime is purchased from U.S. GE company, uses phosphorus
It after acid buffer PBS (pH7.4) aquation 24 hours, is washed three times with PBS, after the sterilizing of PBS mesohigh, microsporidian training is added
Nutrient solution makes microcarrier stick surface area up to 4400cm2/g。
Culture medium is the culture medium MX10 containing 10% calf serum, the water solubility chitin of deacetylation containing 10g/L, according to reality
Apply the preparation of 3 method of example.
Nosema locustae: nosema locustae XJ-20, deposit number CGMCC No11170.
6.2 operation sequences:
6.2.1 10L bioreactor culture nosema locustae is used
4 liters of culture medium MX10 and 4g microcarriers containing 10% calf serum, the chitin of water solubility containing deacetylation
Cytodex3 be added bioreactor, counted after microsporidian freeze thawing, adjust number after culture medium is added, make its final concentration of 1
×105Spore/mL, culture solution, which is added, makes microcarrier initial concentration be 0.5g/L after microsporidian kind is added.Adjust control ginseng
Number pH 7.0-7.2, PO2It is 25%, temperature is 28 DEG C, and revolving speed 40rpm makes microcarrier suspension in culture medium.Maintenance is not less than
40rpm is stirred.It was changed with fresh containing 10% calf serum, deacetylation water solubility chitin culture medium MX10 every 10 days
Liquid.It 70th day, is digested by following procedure: stopping stirring, stops adjusting control PO2, pH, keep temperature regulation.Microcarrier
After sedimentation, there are about 500 milliliters of culture solutions in tank, and the 0.025M sodium citrate solution of 800 milliliters of trypsase containing 600mg is added
(PBS, not calcium ions and magnesium ion), suitably stirring liquid, every 15-30 minute microscopically observation confirmation sporozoite reality
It is detached from microcarrier, inhibits liquid (inhibitor containing 1mg/mL is purchased from Sigma Co., USA) to terminate reaction with 800mL pancreatin.Culture period
Between every 5 days, measure micro- spore density.
6.2.2 10L bioreactor culture nosema locustae is used
4 liters of culture medium MX10 and 7g microcarriers containing 10% calf serum, the chitin of water solubility containing deacetylation
Cytodex3 be added bioreactor, counted after microsporidian freeze thawing, adjust number after culture medium is added, make its final concentration of 1
×105Spore/mL, culture solution, which is added, makes microballoon concentration 1.4g/L.Adjust control parameter pH7.0-7.2, PO2It is 25%, temperature
It is 28 DEG C, revolving speed 40rpm makes microcarrier suspension in culture medium.Maintenance is stirred not less than 40rpm.Every 10 days with fresh
Change liquid containing 10% calf serum, deacetylation water solubility chitin culture medium MX10.70th day, enzyme was carried out by following procedure
Solution: stop stirring, stop adjusting control PO2, pH, keep temperature regulation.After microcarrier sedimentation, there are about 800 milliliters of culture solutions to exist
In tank, the 0.025M sodium citrate solution (PBS, not calcium ions and magnesium ion) of 1000 milliliters of trypsase containing 600mg is added,
Appropriate stirring liquid actually detaches microcarrier every 15-30 minutes microscopically observation confirmation sporozoites, is pressed down with 1000mL pancreatin
Liquid (inhibitor containing 1mg/mL is purchased from Sigma Co., USA) processed terminates reaction.Every 5 days during culture, it is close to measure micro- spore
Degree.
6.2.3 2L bioreactor culture nosema locustae is used
0.5 liter of culture medium MX10 and 0.6g microcarrier containing 10% calf serum, the chitin of water solubility containing deacetylation
Cytodex3 be added bioreactor, counted after microsporidian freeze thawing, adjust number after culture medium is added, make its final concentration of 1
×105Spore/mL, culture solution, which is added, makes microcarrier concentration 0.3g/L after microsporidian kind is added.Adjust control parameter pH
7.0-7.2, PO2It is 25%, temperature is 28 DEG C, and maintenance is stirred not less than 40rpm.Every 10 days with fresh small containing 10%
Cow's serum, deacetylation water solubility chitin culture medium MX10 change liquid.It 70th day, is digested by following procedure: stopping stirring,
Stop adjusting control PO2, pH, keep temperature regulation.After microcarrier sedimentation, there are about 400 milliliters of culture solutions in tank, is added 500
The 0.025M sodium citrate solution (PBS, not calcium ions and magnesium ion) of milliliter trypsase containing 600mg, suitably stirring liquid,
Microcarrier is actually detached every 15-30 minutes microscopically observation confirmation sporozoites, inhibits liquid (to contain 1mg/mL with 500mL pancreatin
Inhibitor is purchased from Sigma Co., USA) terminate reaction.Every 5 days during culture, micro- spore density is measured.
6.3 result
It is grown for detection microsporidian, microcarrier suspension duplicate sample is periodically taken in incubation, with cell counter system meter
Number, takes duplicate sample average value, sees Fig. 1.
Claims (7)
1. a kind of nosema locustae (Nosema locustae), is named as XJ-20, it is characterised in that the micro- spore of the locust
Sub- worm is the separation from Asiatic migratory locust (Locusta migratoria L.), reaches for 10 generations in locust body, in vitro culture reaches
It is obtained after 10 generations, is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, the preservation time is: 2015
November 3, deposit number are CGMCC No.11170.
2. nosema locustae described in claim 1 is preparing the application in biological insecticides.
3. a kind of for cultivating the culture medium of nosema locustae described in claim 1, it is characterised in that the culture medium
Contain following component:
1) insect source property, water solubility, deacetylation chitin 10g/L;
2) protein extract:
Include lactoalbumin hydrolysate 1500mg/L, yeast extract 1500mg/L, trypsasePhosphate broth 1500mg/L, tire
Globulin 10mg/L, cromoci 50mg/L, inosine 100mg/L and bovine serum albumin(BSA) V 5000mg/L;
3) viscosity replenishers PVP K-90 250mg/L;
4) inorganic salt mixt:
Include NaH2PO4·2H2O 507mg/L;NaHCO3300mg/L;KCl 1720mg/L;CaCl2·2H2O 750mg/L;
CuCl2·H2O 0.1mg/L;CoCl2·6H2O 0.03mg/L;FeSO4·7H2O 0.28mg/L;MgCl2·4H2O 1140mg/
L;MgSO4·7H2O 3269mg/L;MnCl2·4H2O 0.01mg/L;NaCl 1425mg/L;NaH2PO4·4H2O 580mg/
L;(NH4)6(Mo7O24)·4H2O 0.02mg/L and ZnCl20.02mg/L;
5) sugared mixture:
Include D-Glucose 2917mg/L;Fructose 20.9mg/L;Sucrose 11865mg/L;Malic acid 306mg/L;Alpha- ketone penta
Diacid 169mg/L;Succinic acid 27.4mg/L;Fumaric acid 25.2mg/L;Maltose 500mg/L;
6) ispol:
Include L-alpha- alanine 131.5mg/L;Beta- alanine 234mg/L;L- R-gene 692mg/L;L- asparagus fern
Amide 797mg/L;L-Aspartic acid 797mg/L;L-cysteine 10.5mg/L;Pidolidone 1000mg/L;L-Glutamine
750mg/L;Glycine 371mg/L;L-Histidine 1142mg/L;L-Isoleucine 396mg/L;L-Leu 157mg/L;L- Guang
Propylhomoserin disodium 60mg/L;L- hydroxyproline 400mg/L;L-Lysine hydrochloride 610mg/L;L-methionine 521mg/L;L- phenylpropyl alcohol
Propylhomoserin 562mg/L, L-PROLINE 396mg/L;DL-tryptophan 559mg/L;L-threonine 173mg/L;L-Trp 91.5mg/
L, l-tyrosine 21mg/L;L-tyrosine disodium 180mg/L;Valine 292mg/L and L-Histidine 1142mg/L;
7) vitamin mixtures:
Include biotin 0.123mg/L;D-VB5 calcium 0.89mg/L;Choline chloride 10.85mg/L;Folic acid 0.125mg/L;I- flesh
Alcohol 0.285mg/L;Niacin 0.165mg/L;Puridoxine hydrochloride 0.285mg/L;Riboflavin 0.125mg/L;Thiamine hydrochloride
0.125mg/L;Vitamin B12 0.12mg/L and p-aminobenzoic acid 0.245mg/L;
8) fetal calf serum that volumn concentration is 20% or 30%;
Each ingredient is substantially soluble in pure water, adjusting medium pH to 6.3, after aseptic filtration to obtain the final product.
4. purposes of the culture medium as claimed in claim 3 in culture nosema locustae, the nosema locustae, name
For XJ-20, it is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number CGMCC
No.11170。
5. a kind of suspension culture method of nosema locustae, it is characterised in that the following steps are included:
(1) culture medium as claimed in claim 3 is added into bioreactor, average diameter under drying regime, which is then added, is
The starting final concentration of 50-300 μm of microcarrier, microcarrier reaches 0.1-3g/L;
(2) in the culture medium containing microcarrier obtained to step (1), nosema locustae, the micro- spore of the locust is added
Worm is named as XJ-20, is preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number CGMCC
No.11170;
(3) control parameter pH 7.0-7.2, PO are adjusted2It is 25%, temperature is 28-30 DEG C, and maintenance is stirred not less than 40rpm,
Liquid was changed with the culture medium in fresh step (1) every 10 days;
(4) at the 50th day of culture, after microcarrier sedimentation separation, the citric acid containing trypsase is added into the culture solution of retention
Sodium solution is slightly agitated for, and is confirmed the case where sporozoite is detached from microcarrier every 15-30 minutes microscopically observations, is used tryptose
Enzyme inhibit liquid terminate reaction to get.
6. suspension culture method as claimed in claim 5, which is characterized in that the volume of culture bioreactor is 3-30L.
7. suspension culture method as claimed in claim 6, which is characterized in that the volume of culture bioreactor is 10L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510890754.3A CN105385601B (en) | 2015-12-07 | 2015-12-07 | A kind of nosema locustae and its suspension culture method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510890754.3A CN105385601B (en) | 2015-12-07 | 2015-12-07 | A kind of nosema locustae and its suspension culture method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105385601A CN105385601A (en) | 2016-03-09 |
CN105385601B true CN105385601B (en) | 2018-12-07 |
Family
ID=55418386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510890754.3A Expired - Fee Related CN105385601B (en) | 2015-12-07 | 2015-12-07 | A kind of nosema locustae and its suspension culture method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105385601B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106434526A (en) * | 2016-12-24 | 2017-02-22 | 严志海 | Non-serum non-animal-origin-additive insect cell culture medium |
CN109169645B (en) * | 2018-09-26 | 2020-09-04 | 中国农业大学 | Synergist for locust microspore biological preparation |
CN113862213B (en) * | 2019-11-08 | 2023-02-07 | 青岛农业大学 | Migratory locust cell line and application thereof |
CN112980693B (en) * | 2021-03-03 | 2023-04-07 | 西南大学 | Method for separating and purifying microsporidian polar tubes |
CN113274890B (en) * | 2021-06-29 | 2022-05-17 | 江苏厚生新能源科技有限公司 | Porous high-permeability polyethylene sewage treatment membrane and preparation method thereof |
CN116063746B (en) * | 2022-08-18 | 2024-04-02 | 中国农业科学院深圳农业基因组研究所 | Method for improving mechanical property of chitosan material and prepared chitosan composite material |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1226900A (en) * | 1997-05-14 | 1999-08-25 | 农林水产省蚕丝、昆虫农业技术研究所长代表的日本国 | Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore |
CN1317565A (en) * | 2001-05-28 | 2001-10-17 | 中国农业大学 | Locust, microsporidian and East-Asia migratory locust strain product and its preparing process |
CN102250772A (en) * | 2011-06-24 | 2011-11-23 | 中国农业大学 | Antonospora locustae strain and application thereof in prevention and control of locust |
WO2014170364A1 (en) * | 2013-04-19 | 2014-10-23 | Bayer Cropscience Ag | Binary insecticidal or pesticidal mixture |
-
2015
- 2015-12-07 CN CN201510890754.3A patent/CN105385601B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1226900A (en) * | 1997-05-14 | 1999-08-25 | 农林水产省蚕丝、昆虫农业技术研究所长代表的日本国 | Chitin beads, chitosan beads, process for preparing these beads, carrier comprising said beads, and process for preparing microsporidian spore |
CN1317565A (en) * | 2001-05-28 | 2001-10-17 | 中国农业大学 | Locust, microsporidian and East-Asia migratory locust strain product and its preparing process |
CN102250772A (en) * | 2011-06-24 | 2011-11-23 | 中国农业大学 | Antonospora locustae strain and application thereof in prevention and control of locust |
WO2014170364A1 (en) * | 2013-04-19 | 2014-10-23 | Bayer Cropscience Ag | Binary insecticidal or pesticidal mixture |
Also Published As
Publication number | Publication date |
---|---|
CN105385601A (en) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105385601B (en) | A kind of nosema locustae and its suspension culture method and application | |
Ribes et al. | Zygomycetes in human disease | |
Benny et al. | 8 Zygomycetous fungi: phylum entomophthoromycota and subphyla kickxellomycotina, mortierellomycotina, mucoromycotina, and zoopagomycotina | |
JP3368323B2 (en) | Chitin beads, chitosan beads, a method for producing these beads, a carrier comprising these beads, and a method for producing microsporidian spores | |
CN102552335B (en) | Traditional Chinese medicine health care product, its preparation method and its application | |
CN102242069A (en) | Paecilomycescicadae (Miq.)Samson and application thereof | |
CN102893807A (en) | Cordyceps militaris (L) link as well as preparation method and application thereof | |
CN111500482B (en) | Clostridium perfringens type A strain of sheep, inactivated vaccine and vaccine preparation method | |
CN101225362A (en) | Artificial culturing method for cicade flower | |
Samanta et al. | Cutaneous, subcutaneous and systemic mycology | |
Richardson et al. | Lichen physiology: X. The isolated algal and fungal symbionts of Xanthoria aureola | |
CN101248799A (en) | Verticillium lecanii pesticides and uses thereof | |
CN102294026A (en) | Milk cow streptococcal mastitis inactivated vaccine and preparation method thereof | |
CN105106946B (en) | A kind of cattle and sheep foot rot oil emulsion vaccine and preparation method thereof | |
CN102960276B (en) | Cultivation method of Chlamys nobilis new strain enriched with DNA (Deoxyribonucleic Acid) and application thereof | |
KR20130096367A (en) | Fermented insect's natural food comprising sericulture products and manufacturing method thereof | |
CN101991847A (en) | Triple inactivated vaccine against dairy cattle mastitis and preparation method thereof | |
CN106173209A (en) | A kind of nematode-destroying fungus powderous preparations and application thereof | |
CN100569285C (en) | The application of immunostimulating complex in preparation fish immunity preparation | |
Elston et al. | Isolation and in vitro characteristics of chinook salmon (Oncorhynchus tshawytscha) rosette agent | |
CN1724068A (en) | Method for preparing intensified inactivated cholera fowl vaccine | |
CN109152793A (en) | New immunology product | |
JP7394393B2 (en) | Tomato pathogenic fungi detection device and detection method using the same | |
CN101914458B (en) | Candida albicans (mannose protein complex) strain | |
CN110420324A (en) | Immunogenic composition of the Staphylococcal antigen containing rabbit and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181207 |